76 results
8-K
EX-99.1
ZOM
Zomedica Corp
9 May 24
Performance Sets New Record for First Quarter Revenue
4:17pm
to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact
8-K
EX-99.1
ZOM
Zomedica Corp
15 Mar 24
Zomedica Provides Corporate NYSE American Listing Update
7:46am
pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other risk factors
DEFA14A
ZOM
Zomedica Corp
6 Feb 24
Additional proxy soliciting materials
5:14pm
products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations
DEFA14A
ZOM
Zomedica Corp
31 Jan 24
Additional proxy soliciting materials
8:00am
to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other
DEFA14A
l5hbnmmb
26 Jan 24
Additional proxy soliciting materials
12:00am
DEFA14A
g537uvrkg7dc81j
17 Jan 24
Additional proxy soliciting materials
4:01pm
8-K
EX-99.1
sy1vrp4r
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
rlm0 ki7j1
13 Sep 23
Zomedica Provides Corporate Update
5:58pm
8-K
EX-99.1
f79elez
6 Sep 23
Zomedica Closes Acquisition of Structured Monitoring Products adding revolutionary
8:18am
8-K
EX-99.1
ajfud
11 May 23
Results of Operations and Financial Condition
4:27pm
8-K
EX-99.1
7dgxe3yupdn8843qf tp
9 May 23
Other Events
8:57am
8-K
EX-99.1
jx0y h6d3
14 Nov 22
Results of Operations and Financial Condition
4:24pm
8-K
EX-99.1
opl2lgxgigqb x539
24 Aug 22
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
4:57pm
8-K
EX-99.1
rr160yoilgcaaz3mhvp
15 Aug 22
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million
6:12pm